Global analysis of DNA methylation by methyl-capture sequencing reveals epigenetic control of cisplatin resistance in Ovarian cancer cell

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Yu, Wei ^a,b   Jin, Chengmeng ^a   Lou, Xiaoyan ^a   Han, Xu ^a   Li, Lisha ^a   He, Yinghua ^c   Zhang, Hongyu ^c   Ma, Kelong ^c   Zhu, Jingde ^c   Cheng, Lihua ^a   Lin, Biaoyang ^a,d,e  

^a ZHEJIANG UNIVERSITY   (China)

^b DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d SWEDISH MEDICAL CENTER   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BISULFITE; CISPLATIN; CYTOSINE; GUANINE; ANTINEOPLASTIC AGENT;

ANALYTIC METHOD; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER MODEL; CANCER RESISTANCE; CELL STRAIN; CELL STRAIN A2780; CELL STRAIN A2780CP; CELL STRAIN BCL2L1; CELL STRAIN PRKCE; CELL STRAIN PTK6; CHEMOSENSITIVITY; CONTROLLED STUDY; DNA DETERMINATION; DNA METHYLATION; DNA SEQUENCE; EPIGENETICS; GENETIC REGULATION; GENOME ANALYSIS; HUMAN; HUMAN CELL; METHYL CAPTURE SEQUENCING; OVARY CANCER; POLYMERASE CHAIN REACTION; DRUG RESISTANCE; FEMALE; GENETIC EPIGENESIS; GENETICS; MASS SPECTROMETRY; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CISPLATIN; DNA METHYLATION; DRUG RESISTANCE, NEOPLASM; EPIGENESIS, GENETIC; FEMALE; HUMANS; MASS SPECTROMETRY; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION;

EID: 84055182550     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029450     Document Type: Article

References (48)

1. Einhorn EH, (1997) Testicular cancer: an oncological success story. Clin Cancer Res 3: 2630-2632.
2. Ozols RF, (1991) Ovarian cancer: new clinical approaches. Cancer Treat Rev 18 (Suppl A): 77-83.
3. Siddik ZH, (2003) Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22: 7265-7279.
4. Mansouri A, Ridgway LD, Korapati AL, Zhang Q, Tian L, et al. (2003) Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells. J Biol Chem 278: 19245-19256.
5. Robertson KD, (2005) DNA methylation and human disease. Nat Rev Genet 6: 597-610.
6. Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, et al. (2000) Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343: 1350-1354.
7. Taniguchi T, Tischkowitz M, Ameziane N, Hodgson SV, Mathew CG, et al. (2003) Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat Med 9: 568-574.
8. Staub J, Chien J, Pan Y, Qian X, Narita K, et al. (2007) Epigenetic silencing of HSulf-1 in ovarian cancer:implications in chemoresistance. Oncogene 26: 4969-4978.
9. Bram EE, Stark M, Raz S, Assaraf YG, (2009) Chemotherapeutic drug-induced ABCG2 promoter demethylation as a novel mechanism of acquired multidrug resistance. Neoplasia 11: 1359-1370.
10. Hu S, Yu L, Li Z, Shen Y, Wang J, et al. (2010) Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo. Cancer Biol Ther 10: 788-795.
11. Boettcher M, Kischkel F, Hoheisel JD, (2010) High-definition DNA methylation profiles from breast and ovarian carcinoma cell lines with differing doxorubicin resistance. PLoS One 5: e11002.
12. Chang X, Monitto CL, Demokan S, Kim MS, Chang SS, et al. (2010) Identification of hypermethylated genes associated with cisplatin resistance in human cancers. Cancer Res 70: 2870-2879.
13. Li M, Balch C, Montgomery JS, Jeong M, Chung JH, et al. (2009) Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer. BMC Med Genomics 2: 34.
14. Down TA, Rakyan VK, Turner DJ, Flicek P, Li H, et al. (2008) A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis. Nat Biotechnol 26: 779-785.
15. Serre D, Lee BH, Ting AH, (2010) MBD-isolated Genome Sequencing provides a high-throughput and comprehensive survey of DNA methylation in the human genome. Nucleic Acids Res 38: 391-399.
16. Brinkman AB, Simmer F, Ma K, Kaan A, Zhu J, et al. (2010) Whole-genome DNA methylation profiling using MethylCap-seq. Methods 53: 232-236.
17. Kido Y, Khokhar AR, Siddik ZH, (1993) Differential cytotoxicity, uptake and DNA binding of tetraplatin and analogous isomers in sensitive and resistant cancer cell lines. Anticancer Drugs 4: 251-258.
18. Harris RA, Wang T, Coarfa C, Nagarajan RP, Hong C, et al. (2010) Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications. Nat Biotechnol 28: 1097-1105.
19. Chavez L, Jozefczuk J, Grimm C, Dietrich J, Timmermann B, et al. (2010) Computational analysis of genome-wide DNA methylation during the differentiation of human embryonic stem cells along the endodermal lineage. Genome Res 20: 1441-1450.
20. Bestor TH, (2005) Transposons reanimated in mice. Cell 122: 322-325.
21. Yan PS, Wei SH, Huang TH, (2002) Differential methylation hybridization using CpG island arrays. Methods Mol Biol 200: 87-100.
22. Ruike Y, Imanaka Y, Sato F, Shimizu K, Tsujimoto G, (2010) Genome-wide analysis of aberrant methylation in human breast cancer cells using methyl-DNA immunoprecipitation combined with high-throughput sequencing. BMC Genomics 11: 137.
23. Michalowsky LA, Jones PA, (1987) Differential nuclear protein binding to 5-azacytosine-containing DNA as a potential mechanism for 5-aza-2′-deoxycytidine resistance. Mol Cell Biol 7: 3076-3083.
24. Anisowicz A, Huang H, Braunschweiger KI, Liu Z, Giese H, et al. (2008) A high-throughput and sensitive method to measure global DNA methylation: application in lung cancer. BMC Cancer 8: 222.
25. Kim EH, Park AK, Dong SM, Ahn JH, Park WY, (2010) Global analysis of CpG methylation reveals epigenetic control of the radiosensitivity in lung cancer cell lines. Oncogene 29: 4725-4731.
26. Ohka F, Natsume A, Motomura K, Kishida Y, Kondo Y, et al. (2011) The global DNA methylation surrogate LINE-1 methylation is correlated with MGMT promoter methylation and is a better prognostic factor for glioma. PLoS One 6: e23332.
27. Su HY, Lai HC, Lin YW, Liu CY, Chen CK, et al. (2009) Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway. Int J Cancer 127: 555-567.
28. Marx D, Meden H, Ziemek T, Lenthe T, Kuhn W, et al. (1998) Expression of the p53 tumour suppressor gene as a prognostic marker in platinum-treated patients with ovarian cancer. Eur J Cancer 34: 845-850.
29. Green JA, Berns EM, Coens C, van Luijk I, Thompson-Hehir J, et al. (2006) Alterations in the p53 pathway and prognosis in advanced ovarian cancer: a multi-factorial analysis of the EORTC Gynaecological Cancer group (study 55865). Eur J Cancer 42: 2539-2548.
30. Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, et al. (2008) MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 68: 425-433.
31. Lujambio A, Ropero S, Ballestar E, Fraga MF, Cerrato C, et al. (2007) Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 67: 1424-1429.
32. Lujambio A, Calin GA, Villanueva A, Ropero S, Sanchez-Cespedes M, et al. (2008) A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A 105: 13556-13561.
33. Jaaskelainen M, Nieminen A, Pokkyla RM, Kauppinen M, Liakka A, et al. (2010) Regulation of cell death in human fetal and adult ovaries-role of Bok and Bcl-X(L). Mol Cell Endocrinol 330: 17-24.
34. Dong Z, Wang J, (2004) Hypoxia selection of death-resistant cells. A role for Bcl-X(L). J Biol Chem 279: 9215-9221.
35. Vento MT, Zazzu V, Loffreda A, Cross JR, Downward J, et al. (2010) Praf2 is a novel Bcl-xL/Bcl-2 interacting protein with the ability to modulate survival of cancer cells. PLoS One 5: e15636.
36. Amundson SA, Myers TG, Scudiero D, Kitada S, Reed JC, et al. (2000) An informatics approach identifying markers of chemosensitivity in human cancer cell lines. Cancer Res 60: 6101-6110.
37. Gebauer G, Mirakhur B, Nguyen Q, Shore SK, Simpkins H, et al. (2000) Cisplatin-resistance involves the defective processing of MEKK1 in human ovarian adenocarcinoma 2008/C13 cells. Int J Oncol 16: 321-325.
38. Williams J, Lucas PC, Griffith KA, Choi M, Fogoros S, et al. (2005) Expression of Bcl-xL in ovarian carcinoma is associated with chemoresistance and recurrent disease. Gynecol Oncol 96: 287-295.
39. Zheng Y, Peng M, Wang Z, Asara JM, Tyner AL, (2010) Protein tyrosine kinase 6 directly phosphorylates AKT and promotes AKT activation in response to epidermal growth factor. Mol Cell Biol 30: 4280-4292.
40. Griner EM, Kazanietz MG, (2007) Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 7: 281-294.
41. Ohmori T, Arteaga CL, (1998) Protein kinase C epsilon translocation and phosphorylation by cis-diamminedichloroplatinum(II) (CDDP): potential role in CDDP-mediated cytotoxicity. Cell Growth Differ 9: 345-353.
42. Gately DP, Jones JA, Christen R, Barton RM, Los G, et al. (1994) Induction of the growth arrest and DNA damage-inducible gene GADD153 by cisplatin in vitro and in vivo. Br J Cancer 70: 1102-1106.
43. Li LC, Dahiya R, (2002) MethPrimer: designing primers for methylation PCRs. Bioinformatics 18: 1427-1431.
44. Li R, Yu C, Li Y, Lam TW, Yiu SM, et al. (2009) SOAP2: an improved ultrafast tool for short read alignment. Bioinformatics 25: 1966-1967.
45. Zhu LJ, Gazin C, Lawson ND, Pages H, Lin SM, et al. (2010) ChIPpeakAnno: a Bioconductor package to annotate ChIP-seq and ChIP-chip data. BMC Bioinformatics 11: 237.
46. Alibes A, Yankilevich P, Canada A, Diaz-Uriarte R, (2007) IDconverter and IDClight: conversion and annotation of gene and protein IDs. BMC Bioinformatics 8: 9.
47. Zeeberg BR, Feng W, Wang G, Wang MD, Fojo AT, et al. (2003) GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol 4: R28.
48. Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, et al. (1999) KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 27: 29-34.